This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Weiss, Glen
Item Type | Name |
Concept
|
Antibodies, Monoclonal, Humanized
|
Academic Article
|
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
|
Academic Article
|
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
|
Academic Article
|
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
|
Academic Article
|
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.
|
Academic Article
|
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
|
Academic Article
|
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.
|
Academic Article
|
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
|
Academic Article
|
Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
|
Academic Article
|
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
|
- Antibodies Monoclonal Humanized